ZOLPIDEM TARTRATE (zolpidem tartrate) by Molecular Devices is 12. Approved for insomnia. First approved in 2012.
Drug data last refreshed 22h ago
12.1 Mechanism of Action Zolpidem is a GABA A receptor positive modulator presumed to exert its therapeutic effects in the short-term treatment of insomnia through binding to the benzodiazepine site of α1 subunit containing GABA A receptors, increasing the frequency of chloride channel opening…
Worked on ZOLPIDEM TARTRATE at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo
Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions
Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions